Ganciclovir‐Resistant Cytomegalovirus in Organ Transplant Recipients
Open Access
- 1 October 2002
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 35 (7) , 866-872
- https://doi.org/10.1086/342385
Abstract
Ganciclovir-resistant (GanR) cytomegalovirus (CMV) is an emerging clinical problem in organ transplant recipients, particularly recipients of kidneyKeywords
This publication has 36 references indexed in Scilit:
- Cytomegalovirus UL97 Phosphotransferase Mutations That Affect Susceptibility to GanciclovirThe Journal of Infectious Diseases, 2002
- Prophylaxis for CMV should not now replace pre‐emptive therapy in solid organ transplantationReviews in Medical Virology, 2001
- Preemptive Therapy Versus Universal Prophylaxis with Ganciclovir for Cytomegalovirus in Solid Organ Transplant RecipientsClinical Infectious Diseases, 2001
- Prevention dof recurrent cytomegalovirus disease in renal and liver transplant recipients: effect of oral ganciclovirTransplant Infectious Disease, 2000
- Cytomegalovirus (CMV) DNA Load Predicts Relapsing CMV Infection after Solid Organ TransplantationThe Journal of Infectious Diseases, 2000
- Cytomegalovirus UL97 and Glycoprotein B (gB) Sequences in Tissues from Immunocompromised Patients with Ganciclovir-resistant Virus InfectionScandinavian Journal of Infectious Diseases, 1999
- FAILURE OF GANCICLOVIR TREATMENT ASSOCIATED WITH SELECTION OF A GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS STRAIN IN A LUNG TRANSPLANT RECIPIENTTransplantation, 1997
- DEVELOPMENT OF GANCICLOVIR RESISTANCE DURING TREATMENT OF PRIMARY CYTOMEGALOVIRUS INFECTION AFTER LIVER TRANSPLANTATION1Transplantation, 1997
- MOLECULAR ANALYSIS OF HUMAN CYTOMEGALOVIRUS STRAINS FROM TWO LUNG TRANSPLANT RECIPIENTS WITH THE SAME DONOR1Transplantation, 1996
- Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised PatientsNew England Journal of Medicine, 1989